neoadjuvant chemotherapy (cisplatin, 5-fluorouracil)

TERMINATED · PHASE3 · Esophageal Neoplasms, Squamous Cell Cancer

difficulty in recruitment

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.